IL13RA2 抗体
-
- 抗原 See all IL13RA2 抗体
- IL13RA2 (Interleukin 13 Receptor, alpha 2 (IL13RA2))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This IL13RA2 antibody is un-conjugated
-
应用范围
- ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
- 特异性
- Recognises the IL-13 receptor a2 (IL-13 Ra2), a 44 kDa protein
- 纯化方法
- Ion exchange chromatography
- 过滤
- 0.22 μm filtered
- 免疫原
- IL-13Ra2 transfected CHO cell line,Myeloma X63/AG.8653 x Balb/c spleen cells
- 克隆位点
- B-D13
- 亚型
- IgG1 kappa
- Top Product
- Discover our top product IL13RA2 Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
- 储存液
- Without preservative
- 储存条件
- 4 °C
- 储存方法
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
-
-
Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 12, Issue 15, pp. 4678-86, (2006) (PubMed).
: "Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease." in: Molecular cancer therapeutics, Vol. 3, Issue 2, pp. 137-47, (2004) (PubMed).
: "IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 6, pp. 3775-83, (2004) (PubMed).
: "Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 9, Issue 17, pp. 6381-8, (2003) (PubMed).
: "Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 8, Issue 6, pp. 1948-56, (2002) (PubMed).
: "Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 169, Issue 1, pp. 407-14, (2002) (PubMed).
: "IL-13 receptor-targeted cytotoxin cancer therapy leads to complete eradication of tumors with the aid of phagocytic cells in nude mice model of human cancer." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 169, Issue 12, pp. 7119-26, (2002) (PubMed).
: "Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas." in: Cancer research, Vol. 60, Issue 5, pp. 1168-72, (2000) (PubMed).
: "
-
Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 12, Issue 15, pp. 4678-86, (2006) (PubMed).
-
- 抗原
- IL13RA2 (Interleukin 13 Receptor, alpha 2 (IL13RA2))
- 别名
- CD213a2 (IL13RA2 产品)
- 别名
- il-13ra2 antibody, sb:cb602 antibody, si:dkeyp-110c7.6 antibody, CD213A2 antibody, CT19 antibody, IL-13R antibody, IL13BP antibody, CD213a2 antibody, IL-13R-alpha-2 antibody, IL13RA2 antibody, interleukin 13 receptor, alpha 2 antibody, interleukin 13 receptor subunit alpha 2 antibody, interleukin 13 receptor subunit alpha 2 S homeolog antibody, il13ra2 antibody, IL13RA2 antibody, il13ra2.S antibody, Il13ra2 antibody
- 背景
- IL-13Ra2
- 分子量
- 74 kDa
-